Eng

Gilead tells developments in clinical trials of Remdesivir against coronavirus

XINHUA
發布於 2020年02月17日07:25

Gilead Sciences tells the developments in clinical trials of Remdesivir, which are being conducted in more than 10 hospitals in Wuhan against the novel coronavirus disease (COVID-19).

更多 Eng 相關文章

Lebanese civilians suffer heavy losses amid persistent border tensions with Israel
XINHUA
Hong Kong’s best fusion dishes bring a globe-trotting journey around the world to the tip of your tongue
Tatler Hong Kong
China's urban passenger trips jump 27.7 pct in 2023
XINHUA
Indonesian student designs a life in fashion
XINHUA
Guest Opinion: Who is really betting against America?
XINHUA
China's bond market issuances hit 7.16 trln yuan in March
XINHUA
Stunning rainbow appears above Hukou Waterfall on Yellow River
XINHUA
Xinhua News | Xi meets U.S. secretary of state
XINHUA
Mario Ho, Chairman and co-CEO of NIP Group, Named Among "2024 Forbes China Bold Pioneers Selection"
PR Newswire (美通社)
Xi tells Blinken competition should not be zero-sum game
XINHUA
Lynk & Co's EM-P Takes Center Stage at Beijing Auto Show
PR Newswire (美通社)
Driving Impact with AI: Brian Impact Foundation Joins AVPN Global Conference 2024
PR Newswire (美通社)
GLOBALink | Experts hail Chinese e-mobility technology as Kenya advances green transportation
XINHUA
Inc & Co brand incspaces Announces €1.5M Investment in Barcelona Office with European Expansion Plans & Global Pivot
PR Newswire (美通社)
Chinese foreign minister receives written interview with Al Jazeera Media Network
XINHUA
6.9-magnitude quake rocks Japan, tremors felt in Tokyo
XINHUA
Kenya allocates 30 mln USD for flood response as death toll reaches 70
XINHUA
Xinhua News | Hong Kong-Zhuhai-Macao Bridge receives over 10 mln vehicles
XINHUA